QT-prolongation: Clinical Trials

3 trials for QT-prolongation, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. .

Follow QT-prolongation: new trials by email Literature Review of QT-prolongation trials Research Report on QT-prolongation

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital
Haloperidol, azi/clari/erythromycin, levo/moxifloxacin, co-trimoxazole, vori/keto/flu/itraconazole, methadone, tacrolimus, sunitinib - Delirium, QT-prolongation
CompletedKU Leuven1782014-02-012015-07-28
Drug Interactions With Risk of QT-prolongation in a General Hospital
Haloperidol - QT-prolongation
CompletedKU Leuven2222013-07-012014-06-11
QT-prolongation in Psychiatric Hospitals
drugs linked with QT-prolongation - QT-prolongation
CompletedKU Leuven1522010-10-012015-07-28

Narrower conditions

Long QT Syndrome (3)  ·  Torsades de Pointes (3)  ·  Delirium (1)

Broader conditions

Arrhythmias, Cardiac (3)  ·  Cardiac Conduction System Disease (3)  ·  Cardiovascular Abnormalities (3)  ·  Cardiovascular Diseases (3)  ·  Congenital Abnormalities (3)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3)  ·  Heart Defects, Congenital (3)  ·  Heart Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Tachycardia (3)  ·  Tachycardia, Ventricular (3)  ·  Confusion (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)

Interventions

Haloperidol (2)  ·  Erythromycin (1)  ·  Methadone (1)  ·  Sunitinib (1)  ·  Tacrolimus (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)

Sponsors

KU Leuven (3)

Countries

Belgium (3)

Top investigators

Eline Vandael, PhD-student (3)

Results publications

PMID 28281228